If you have spent any time reading about hair loss, you have seen three letters everywhere: DHT. Dihydrotestosterone is the hormone most directly responsible for androgenetic alopecia, the medical term for pattern hair loss. But knowing that DHT causes hair loss and understanding how it actually works at the follicle level are two different things. This guide explains the mechanism in plain language, clarifies common misconceptions, and shows you what to track so you can measure whether your follicles are responding to whatever approach you choose.
TL;DR
- DHT is converted from testosterone by the enzyme 5-alpha reductase in the scalp.
- It binds to androgen receptors in genetically sensitive follicles, gradually shrinking them until they produce only fine vellus hair.
- Blood DHT levels do not predict hair loss — follicle receptor density and sensitivity do.
- Tracking density over time is the only way to know whether your follicles are miniaturizing.
Important
This article is educational and not medical advice. If you are worried about sudden shedding, scalp symptoms, or side effects, talk to a licensed clinician.
What is DHT and where does it come from?
Dihydrotestosterone is an androgen hormone derived from testosterone. An enzyme called 5-alpha reductase converts about 5-10% of circulating testosterone into DHT. This conversion happens in several tissues, including the prostate, skin, and — crucially — the hair follicles of the scalp. DHT is roughly three to six times more potent than testosterone at binding to androgen receptors, which is why it has such an outsized effect on follicles despite being present in smaller quantities.
There are two types of 5-alpha reductase. Type I is found mainly in the skin and sebaceous glands. Type II is concentrated in the hair follicles, prostate, and genital skin. Most hair loss treatments that target DHT — like finasteride — work by inhibiting Type II 5-alpha reductase, reducing DHT production at the follicle level.
How DHT causes hair loss: the miniaturization cycle
DHT does not kill hair follicles outright. Instead, it triggers a gradual process called follicular miniaturization. Here is what happens step by step:
- DHT binds to androgen receptors in the dermal papilla cells at the base of genetically sensitive follicles. Not all follicles have the same receptor density — those at the temples and crown typically have more receptors than those at the sides and back.
- The growth phase (anagen) shortens. A healthy terminal hair grows for two to seven years. Under DHT influence, each successive growth cycle becomes shorter, producing hair that does not reach its full length or thickness before entering the resting phase.
- The follicle physically shrinks. The dermal papilla receives less blood supply and produces a progressively thinner hair shaft with each cycle. Over many cycles, what was once a thick terminal hair becomes a fine, barely visible vellus hair.
- Eventually, the follicle stops producing visible hair. After enough miniaturization cycles, the follicle may produce only a microscopic strand or cease production entirely. At this stage, reversal becomes extremely difficult.
This entire process can take years to decades, which is why pattern hair loss is gradual and why consistent tracking matters. By the time you notice thinning in the mirror, multiple miniaturization cycles have already occurred.
Why some follicles are affected and others are not
If DHT circulates through the entire bloodstream, why does hair loss follow a predictable pattern — temples and crown first, sides and back last? The answer lies in genetics, not hormone levels.
Follicles in different scalp regions have different concentrations of androgen receptors. The follicles at your temples and vertex inherited a higher density of these receptors, making them more sensitive to DHT. The follicles along the sides and back of your head (the “donor area” in hair transplant terminology) have far fewer receptors and remain largely unaffected, even in advanced baldness.
This is why two men with identical DHT levels can have completely different hair loss patterns. The genetic component is polygenic — multiple genes from both parents influence receptor density, 5-alpha reductase activity, and follicle sensitivity. Research suggests that the androgen receptor gene on the X chromosome plays a significant role, but it is far from the only gene involved.
Common misconceptions about DHT and hair loss
“High testosterone means more hair loss”
Not true. Blood testosterone and DHT levels do not reliably predict who will lose hair. A man with below-average testosterone can experience severe pattern loss if his follicles have high receptor sensitivity. The key variable is local follicle genetics, not circulating hormone levels.
“Blocking DHT will eliminate all hair loss”
DHT is the primary driver of androgenetic alopecia, but not the only factor. Scalp inflammation, oxidative stress, and reduced blood flow also contribute. Finasteride reduces scalp DHT by roughly 60-70%, which is enough to slow or stop miniaturization in most men, but results vary based on individual biology.
“DHT is a bad hormone that should be eliminated”
DHT plays important roles in the body including muscle development, sexual function, and body hair growth. It is only “bad” from the narrow perspective of scalp hair follicles with genetic sensitivity. This is why treatment strategies aim to reduce DHT at the follicle level or block receptor binding, not eliminate the hormone entirely.
How DHT blockers work
The most effective approach to DHT-related hair loss is reducing the amount of DHT that reaches your follicles. There are two main pharmacological strategies:
- 5-alpha reductase inhibitors block the enzyme that converts testosterone to DHT. Finasteride inhibits Type II and reduces scalp DHT by about 60-70%. Dutasteride inhibits both Type I and Type II and reduces scalp DHT by about 90%.
- Androgen receptor blockers prevent DHT from binding to the receptor even when present. Topical anti-androgens like fluridil work this way. They are less commonly prescribed but may have fewer systemic effects since they act locally.
Natural compounds like saw palmetto, green tea (EGCG), and pumpkin seed oil have shown mild 5-alpha reductase inhibition in some studies, but their effect sizes are considerably smaller than prescription medications. If you choose a natural approach, objective tracking becomes even more important — you need data to know whether a weaker intervention is actually working for you.
What to track if you suspect DHT-driven hair loss
Understanding DHT is useful, but it does not tell you what is happening to your specific follicles right now. Only measurement does. Here is what to focus on:
- Density at the temples and crown. These are the DHT-sensitive zones. Take standardized photos weekly and compare them over 8-12 weeks. Balding AI scores these zones on a 0-10 scale so you can track trends objectively.
- Hair caliber (thickness). Miniaturization shows up as thinner individual strands before overall density drops. If your thickness scores are declining while density holds steady, miniaturization may be in its early stages.
- Comparison between zones. The sides and back versus the top serve as your natural control group. If density at the crown is declining while the sides remain stable, that asymmetry is a strong signal of androgen-driven loss.
- Response to treatment. If you start a DHT blocker, track density and thickness at the sensitive zones for a minimum of six months. Improvement is slow because follicles need multiple growth cycles to recover, and initial shedding is common in the first few weeks.
DHT and hair loss: the bottom line
DHT is the primary biological driver of pattern hair loss, but it acts through a slow, reversible (in early stages) process of follicle miniaturization. Your blood hormone levels matter far less than the genetic sensitivity of your individual follicles. Treatments that reduce DHT at the scalp level can slow or halt miniaturization, but the only way to know whether your follicles are actually responding is to measure density and thickness over time. Understanding the mechanism is the first step. Tracking what it does to your hair is the step that actually changes outcomes.
